Syon Capital’s Boston Scientific BSX Stock Holding History

Syon Capital’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.52M	Sell	24,155 -3,746	-13%	-$300K	0.08%	195
2025 Q4	$2.66M	Buy	27,901 +691	+3%	+$67.7K	0.13%	116
2025 Q3	$2.66M	Buy	27,210 +1,745	+7%	+$181K	0.14%	101
2025 Q2	$2.74M	Buy	25,465 +4,277	+20%	+$433K	0.18%	81
2025 Q1	$2.14M	Buy	21,188 +2,239	+12%	+$225K	0.17%	88
2024 Q4	$1.69M	Sell	18,949 -1,009	-5%	-$88.8K	0.15%	98
2024 Q3	$1.67M	Buy	19,958 +20	+0.1%	+$1.58K	0.15%	104
2024 Q2	$1.54M	Buy	19,938 +307	+2%	+$22.5K	0.14%	109
2024 Q1	$1.34M	Sell	19,631 -18,507	-49%	-$1.19M	0.13%	120
2023 Q4	$2.2M	Buy	38,138 +19,888	+109%	+$1.06M	0.09%	135
2023 Q3	$964K	Buy	+18,250	New	+$957K	0.12%	110

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Syon Capital's BSX Position: Q1 2026 in Review

Syon Capital reduced its Boston Scientific (BSX) stake by 13% in Q1 2026, selling an estimated $300K and leaving 24,155 shares worth $1.52M. The position accounts for 0.08% of the portfolio, ranked #195.

Syon Capital first reported a position in BSX in Q3 2023 and has held it in 11 quarters since. The position peaked at $2.74M in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Syon Capital held 24,155 shares of Boston Scientific worth $1.52M as of Q1 2026.
Syon Capital sold 3,746 Boston Scientific shares in Q1 2026, an estimated $300K.
Boston Scientific made up 0.08% of Syon Capital's portfolio in Q1 2026, its #195 holding.
Syon Capital first reported a position in Boston Scientific in Q3 2023 and has held it in 11 quarters since.
Syon Capital's Boston Scientific position peaked at $2.74M in Q2 2025.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Syon Capital's 13F filing for Q1 2026, filed 13 May 2026.